Neuropeptides and polypeptide hormones destined for secretion are synthesized as inactive precursors that undergo modification en route through the secretory pathway (1) (2) (3) (4) . To generate a bioactive peptide, many precursors are endoproteolytically cleaved in a process that begins in the TGN 1 or immature secretory granules (5) (6) (7) . Additional modifications such as endoproteolysis, exoproteolysis, N-acetylation, or ␣-amidation occur during secretory granule maturation (3, (7) (8) (9) (10) . The bifunctional enzyme, peptidylglycine ␣-amidating monooxygenase (PAM), post-translationally modifies approximately half of all mammalian neuropeptides by converting a COOH-terminal glycine into an essential ␣-amide moiety (4, 11, 12) . PAM catalyzes this reaction in consecutive steps involving its two catalytic domains, peptidylglycine ␣-hydroxylating monooxygenase (PHM) and peptidyl-␣-hydroxyglycine ␣-amidating lyase (PAL) (13) (14) (15) (16) (17) . This reaction can be initiated in the TGN (5) but primarily occurs in immature secretory granules (13) . PAM proteins occur in soluble and integral membrane forms in a tissue-specific and developmentally regulated manner (2, 13, 18) . In PAM-1, a type I integral membrane protein (Fig. 1) , the monooxygenase or PHM domain is separated from the lyase or PAL domain by a noncatalytic segment, exon A (19) . Both catalytic domains are intragranular and are followed by a single transmembrane domain and a short, cytosolic COOHterminal domain (CD) (2) . In AtT-20 cells, soluble PAM predominantly enters the regulated secretory pathway, where it is endoproteolytically processed and stored with peptide hormones in secretory granules (20) . Integral membrane PAM-1 undergoes endoproteolysis, generating soluble PHM, which is either stored in secretory granules or secreted in a constitutivelike manner, while PAL remains attached to the membrane (20) . Both membrane PAM and PAL are largely localized to a distal compartment of the TGN at steady-state (21) . Based on antibody internalization studies (22, 23) , the small amount of membrane PAM located on the plasma membrane at steadystate is rapidly internalized and accumulates in perinuclear endosomes before re-entering the TGN.
Routing signals, including dileucine motifs and tyrosine internalization motifs, are located in the cytosolic domains of many integral membrane proteins (24 -28) . PAM-1/899, a COOH-terminally truncated PAM-1 mutant, rapidly accumulates on the cell surface and is unable to support internalization of ectodomain antibody (22, 23) . Although the CD of PAM has a tyrosine-based internalization motif ( Fig. 1) , elimination of this motif does not compromise the ability of membrane PAM to have access to secretory granule enzymes (29) .
Phosphorylation is an important routing determinant for many proteins (30 -34) . In AtT-20 cells, PAM is phosphorylated only when its CD is exposed to cytosol (35) (Fig. 1) . Using purified recombinant PAM COOH-terminal domain, it was established that protein kinase A phosphorylates Ser 921 and protein kinase C phosphorylates Ser 932 and Ser 937 (35) ; Ser 937 is adjacent to the tyrosine internalization motif (Fig. 1) . By ex-pressing PAM-1 with Ser 937 mutated to Ala 937 (PAM-1/S937A) to prevent phosphorylation, we were able to demonstrate altered endocytic trafficking (35) . Antibody internalized by cells expressing PAM-1/S937A is dispersed to lysosomes, while antibody internalized by cells expressing PAM-1 is concentrated in the TGN region; the effects of this mutation on biosynthetic trafficking were not explored (35) .
This study focuses on the role of phosphorylation and dephosphorylation of Ser 937 in both the biosynthetic and endocytic routing of PAM using AtT-20 cells stably transfected with PAM-1 in which Ser 937 was mutated to Ala 937 or Asp 937 (35) . To further our understanding of the biosynthesis and localization of PAM phosphorylated at Ser 937 , a Ser(P) 937 -specific antibody was raised (Fig. 1) . Although phosphorylation at Ser 937 occurs in the ER, the early steps in the trafficking of newly synthesized PAM are not affected by phosphorylation at this site. The inability to phosphorylate Ser 937 limits secretion of soluble PHM and increases the turnover rate of newly synthesized PAM-1. Upon stimulation with phorbol ester, the amount of PAM-1 phosphorylated at Ser 937 increases rapidly, accumulating in the TGN region as well as in large vesicular structures distributed throughout the cytosol. Phosphorylation of PAM-1 at Ser 937 appears to direct both the newly synthesized protein and the internalized protein away from lysosomes, while dephosphorylation at this site is needed for a separate step in late endocytic trafficking.
MATERIALS AND METHODS

Construct
Generation by Site-directed Mutagenesis-A pBluescript plasmid encoding PAM-1 with Ser 937 mutated to Asp 937 (pBS.KrPAM-1/S937D) was created using SOEing polymerase chain reaction (36) . Amplification involved an upstream sense primer (rPAM-1-(2791-2809)) and a mutagenic antisense primer with a codon (underlined) for Asp 937 (5Ј-CCT TTT CTG TCG TAG CCT TT-3Ј) or a mutagenic sense primer (5Ј-AAA GGC TAC GAC AGA AAA GG-3Ј) and the T7 antisense primer. To create pBS.KrPAM-1/S937D, the final amplified fragment was inserted into pBS.KrPAM-1 using the restriction enzymes MscI and XbaI. The DNA region derived from polymerase chain reaction was verified by sequencing. The pBS.KrPAM-1/S937D construct was then inserted into the pCIS expression vector by ligation using Bsp106 and XbaI sites (35) . KrPAM-1/S937A (35) was placed into a pCI.neo mammalian expression vector (Promega) using XhoI and XbaI sites.
Transfection and Generation of Stable Cell Lines-AtT-20 cells were transfected with either pCI.neo.KrPAM-1/S937A or pCIS.KrPAM-1/ S937D using Lipofectin (Sigma) (35) . Stably transfected AtT-20 cell lines were maintained in Dulbecco's modified Eagle's medium/F-12 medium (Life Technologies, Inc.) containing 10% fetal clone serum (HyClone, Logan, UT), 10% NuSerum (Collaborative Research, Bedford, MA), and antibiotics. The medium also contained 0.5 mg/ml G418 when used to select transfected cells and 0.1 mg/ml G418 for maintenance of clonal cell lines. For the following studies, 3-4 clones were used from each cell line with the relative levels of PAM expression in the clones not varying more than 2-fold.
Antibodies/Immunofluorescence Microscopy-Rabbit polyclonal antibodies were used at a dilution of 1:1000 for immunostaining and Western blot analyses and included the following: PHM antibody, JH1764, to PAM-1-(37-382); PAL antibody, JH471, to PAM-1-(463-864); CD antibody, JH571, to PAM-1-(898 -976); and TGN38 antibody, JH1479, to TGN38-(155-249) (21) . Monoclonal antibodies used included the following: CD antibody, 6E6, to PAM-1-(898 -976); 1D4B (Developmental Studies Hybridoma Bank), directed against lysosome-associated membrane protein 1 (LAMP-1) (38) ; and antibody to the cation-independent mannose 6-phosphate receptor (CI-MPR) (kindly provided by Dr. Suzanne Pfeffer, Stanford University School of Medicine) (39) . The rabbit polyclonal antisera were used at a dilution of 1:1000 for immunostaining and Western blot analyses. The CD antibody, 6E6, and the LAMP-1 antibody were used at a dilution of 1:50, while the CI-MPR antibody was diluted 1:20.
Immunofluorescence microscopy was carried out as described previously (23) using a Zeiss Axioskop microscope and a Princeton Instruments Micromax digital camera. Where indicated, a Noran confocal laser scanning fluorescence microscope was used. The simultaneous collection of two fluorescent signals, fluorescein isothiocyanate (green) and Cy3 (red), allowed cells in optical sections of 1 m to be visualized. Cells labeled with only a single fluorescent tag were used as controls (21) . The Cell Biology Core Facility at The Johns Hopkins University School of Medicine provided support for and use of the confocal microscope.
Generation of Ser(P) 937 Antibody-A peptide from the cytosolic domain of PAM was synthesized using monobenzyl-protected Fmoc (N-(9-fluorenyl)methoxycarbonyl)-Ser(P), with and without a COOH-terminal Cys residue, and purified as a monomer or disulfide-linked dimer, respectively: Arg 933 -Lys-Gly-Tyr 936 -Ser(P) 937 -Arg-Lys-Gly-Phe-Asp 942 . The peptide monomer was blocked with citraconic anhydride, conjugated to keyhole limpet hemocyanin (Pierce) with 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide hydrochloride, and deblocked with sodium acetate (pH 4.2). Three rabbits were immunized by Covance (Denver, PA) using a pool of the nonconjugated disulfide-linked dimer and the hemocyanin-peptide conjugate.
The titer and specificity of the Ser(P) 937 antibody were determined with a solid phase assay using the following synthetic peptides: PAM-1-(933-948); PAM-1-(933-942)Ser(P) 937 ; PAM-1-(933-942)Asp 937 . Antibody JH1922 produced a positive response to the synthetic phosphopeptide and no response to the nonphosphorylated peptide. JH1922 was affinity-purified using PAM-1-(933-942)Ser(P) 937 linked to Affi-Gel 10. Affinity-purified antibody was used at a dilution of 1:200. 937 antibody; PAM-1/S937A protein was not detected even when the film was exposed for 3 times longer than the time needed to yield a dark band with the PHM antibody. Thus, the Ser(P) 937 antibody has the required specificity to be used for immunoprecipitation.
Antibody Internalization-Cells were incubated in PAL antiserum (JH471, diluted 1:50) in complete serum-free air medium for 10 min at 37°C and either prepared immediately for immunofluorescence staining or chased in antibody-free medium for 10, 30, or 60 min at 37°C (23, 40) . To distinguish the role of phosphorylation in the internalization of PAM protein during the early and late stages of internalization, a paradigm involving a 20°C temperature block was used to trap PAMrelated proteins in early versus late endosomal compartments (41) . Initially, cells were incubated at 4°C for 60 min with the PAL antiserum to bind the PAM protein on the surface of the cell and to prevent internalization (41) . A subsequent 10-min antibody-free chase at 20°C allowed internalization of PAM/PAL antibody into early endosomal compartments. To sequester PAM/PAL antibody in late endosomal compartments, the cells were incubated with PAL antibody for 90 min at 20°C. The cells then were warmed to 37°C for 10 and 60 min to assess the subcellular localization of the internalized PAM protein.
Metabolic 3Ϫ . Cells were extracted into ice-cold 20 mM NaTES, 10 mM mannitol, and 1% Triton X-100 (TMT, pH 7.4) with protease inhibitors (300 g/ml phenylmethylsulfonyl fluoride, 2 g/ml leupeptin, 10 g/ml ␣ 2 -macroglobulin, 16 g/ml benzamidine, 10 g/ml lima bean trypsin inhibitor) and protein phosphatase inhibitors (5 mM EGTA, 5 mM EDTA, 1 mM sodium orthovanadate, 10 mM sodium pyrophosphate, and 50 mM NaF). Immunoprecipitates were prepared as described. A BioQuant phosphor imager was used for quantitation.
Western Blot Analysis-Cell extracts were fractionated on 10% polyacrylamide, 0.25% N,NЈ-methylene-bisacrylamide/SDS gels (43) , and proteins were transferred to Immobilon-P membranes (Millipore Corp.) (16) . Visualization of the proteins was done using the PAL antibody (JH471) or the Ser(P) 937 -specific antiserum (JH1922) and the Amersham Pharmacia Biotech ECL kit.
RESULTS
Mutant and Wild-type PAM-1 Proteins Exhibit Similar
Steady-state Localization-To establish the steady-state localization of the mutant PAM-1 proteins, AtT-20 cell lines expressing PAM-1, PAM-1/S937A, or PAM-1/S937D were fixed and visualized with a PAM-CD monoclonal antibody. As previously shown, immunostaining was observed in a compact perinuclear region of the AtT-20 PAM-1 and PAM-1/S937A cells identified as the TGN (Fig. 2, A and B) (21, 35, 44) . Furthermore, immunostaining was present at the tips of the processes of the PAM-1 and PAM-1/S937A cells. The same pattern of immunostaining was seen in the AtT-20 PAM-1/S937D cells (Fig. 2C) ; staining was detected at the tips of the cellular processes as well as in a compact perinuclear region that overlapped with staining for TGN38. The AtT-20 PAM-1 and mutant PAM-1 cells were also immunostained with a polyclonal PHM antibody that produced a similar localization pattern (data not shown). Based on these results, the steady-state localization of PAM-1/S937D is not dramatically different from that of wild-type PAM-1 or PAM-1/S937A.
The Ser(P) 937 Antibody Identifies PAM-1 Phosphorylated at This Site-A rabbit polyclonal antibody specific for phosphorylated Ser 937 of the PAM cytosolic domain was raised by immunization with a phosphorylated decapeptide (Fig. 1) . In a solid phase assay, the antibody did not cross-react with the nonphosphorylated peptide. However, it did detect a decapeptide in which Asp 937 had been substituted for Ser 937 (R   933   KGYD   937   RKGFD   942 ), suggesting specificity for a conformation associated with the presence of a negative charge at position 937 rather than for Ser(P) 937 itself. Finally, binding of the Ser(P) 937 antibody to the Ser(P) 937 peptide was not competed by 10 M Asp, Ser(P) or Thr(P). To further test its specificity, AtT-20 PAM-1/S937A cells were immunostained with the Ser(P) 937 antibody. As shown in Fig. 2E , no immunostaining was detected. Since the antibody could not detect a PAM-1 protein that could not be phosphorylated at Ser
937
, cross-reactivity with the 
Ser(P)
937 antibody should be a reliable indication of phosphorylation at this site.
The fact that immunostaining AtT-20 PAM-1 cells with the Ser(P) 937 antibody yields a specific signal demonstrates that some PAM-1 is phosphorylated on Ser 937 in AtT-20 cells (Fig.  2D ). The Ser(P) 937 antibody immunostained a more diffuse perinuclear region of the cell than did the CD monoclonal antibody. Furthermore, the Ser(P) 937 antibody immunostained the tips of the cellular processes with a greater intensity than the CD monoclonal antibody (Fig. 2D, inset) . As expected, based on its cross-reactivity with synthetic peptides, the Ser(P) 937 antibody immunostained AtT-20 PAM-1/S937D cells in the same manner as the CD monoclonal antibody (Fig. 2F) .
To further establish the specificity and reliability of the Ser(P) 937 antibody, membrane extracts prepared from AtT-20 PAM-1, PAM-1/S937A, and PAM-1/S937D cells were subjected to Western blot analysis using antisera specific for PAL and Ser(P) 937 . As previously established (21) , the PAL antibody recognized full-length PAM-1 (120 kDa) as well as membrane PAL (70 kDa) (Fig. 3A) . The PAL antiserum also detected 120-and 70-kDa proteins in AtT-20 cells expressing PAM-1/S937A and PAM-1/S937D. No cross-reactivity was detected in the AtT-20 PAM-1/S937A cells with the Ser(P) 937 antibody, providing further evidence that the Ser(P) 937 antibody cannot detect 4-h chase cell extract sample was not observed consistently and thus is marked as nonspecific. B, data from 3-5 experiments were quantified. The amount of newly synthesized PAM-1 protein present after the 1-h chase was set to 100%, since the amount of labeled 120-kDa PAM protein increased during the first hour of chase due to completion of translation (see A). The recovery of PAM protein after the 4-h chase was determined by adding the amount of 120-kDa protein in the cell extract to the total amount of 45-kDa PHM in both the cell extract and medium at 4 h. C, The amount of PHM secreted by each cell line at 4 h was quantified and compared with the total PAM recovered. Mdm, medium.
PAM protein that does not have a negative charge at position 937 (Fig. 3A) . Importantly, the Ser(P) 937 antibody did detect 120-and 70-kDa proteins in the AtT-20 PAM-1 cell extract. As predicted based on cross-reactivity with synthetic peptides, the Ser(P) 937 937 -specific antibody. This lack of sensitivity reflects the presence of 24 methionine residues in PAM-1 with only 6 methionines in membrane PAL. The ease with which 70-kDa membrane PAL is detected by Western blot versus metabolic labeling (Fig. 3, A versus B ) also suggests that 120-kDa PAM-1 and 70-kDa membrane PAL turn over at different rates.
PAM-1/S937A Yields Less 45-kDa PHM than PAM-1-To assess their metabolism, AtT-20 cells expressing PAM-1/S937A or PAM-1/S937D were biosynthetically labeled with [
35 S]Met. Following a 15-min pulse labeling, the cells were either immediately extracted or chased for 1, 2, or 4 h before extraction. Aliquots of cell extracts and chase media were analyzed by quantitative immunoprecipitation using an antibody specific for PHM. AtT-20 cells expressing wild-type PAM-1 were analyzed for comparison. Immunoprecipitation of PHM proteins from all three cell extracts showed that only a 117-kDa PAM protein was present after the 15-min pulse (Fig. 4A) . In all three cell lines, the size of the newly synthesized PAM protein increased to 120 kDa over the first 1-h chase period due to maturation of oligosaccharides (22, (45) (46) (47) . A more detailed analysis of the early chase times revealed that the time course for sugar modification was similar in the PAM-1, PAM-1/ S937A, and PAM-1/S937D cells (data not shown). Similar results were observed using the PAL and CD polyclonal antibodies to examine PAM-1, but given the difficulty of detecting smaller PAL proteins due to the small number of methionine residues present (as shown in Fig. 3B ), only the PHM data are presented.
Cleavage of 120-kDa PAM-1 to 45-kDa PHM occurs only upon entrance of the newly synthesized protein into immature secretory granules (23) . In AtT-20 PAM-1 cells, 45-kDa PHM was first detected in cell extracts after the 2-h chase, with more 45-kDa PHM present after the 4-h chase (Fig. 4A) . Cleavage of 120-kDa PAM-1 to yield 45-kDa PHM followed a similar time course in the PAM-1/S937A and PAM-1/S937D cells. Consistent with the appearance of 45-kDa PHM, the amount of 120-kDa PAM protein in all three cell lines decreased most noticeably during the 2-4-h chase period. Furthermore, 45-kDa PHM was secreted into the medium, first appearing during the 1-2-h chase (medium data not shown), and accumulating in the medium during the 2-4-h chase in all three cell lines. However, the amount of 45-kDa PHM secreted into the medium by PAM-1/S937A cells was substantially lower than for PAM-1 or PAM-1/S937D cells. As expected, membrane PAL accumulated in the cells during the chase incubation (data not shown) (23), although accurate quantification of the amount of membrane PAL was not possible.
To determine the magnitude of the effect on PHM production and secretion, data from 3-5 experiments were quantified (Fig.  4B ). Only 50% of the newly synthesized PAM/S937A was recovered after 4 h; in contrast, all of the wild-type PAM-1 protein and all of the PAM-1/S937D protein was recovered at the same time (p Յ 0.01) (Fig. 4B) . In quantifying the amount of intact 120-kDa PAM-1 protein (cross-hatched bar) remaining after the 4-h chase, no significant differences among the three cell lines were observed. In contrast, only 20% of the PAM-1/ S937A was recovered as 45-kDa PHM, compared with 65% of the PAM-1 or PAM-1/S937D recovered as 45-kDa PHM (p Յ 0.01).
The amount of PHM secreted by each cell line was also quantified compared with the total PAM recovered (Fig. 4C) . noprecipitated after the 10-and 15-min labeling periods (Fig.  5A) . Immunoprecipitation with the Ser(P) 937 antibody established that some of the newly synthesized 117-kDa PAM-1 was phosphorylated during the 5-min pulse. The amount of PAM-1 protein precipitated with the Ser(P) 937 antibody also increased with longer labeling periods. Increasing amounts of the Ser(P) 937 antibody did not immunoprecipitate more PAM protein (data not shown). The amount of PAM immunoprecipitated by either the PHM or the Ser(P) 937 antiserum following the 5-, 10-, and 15-min pulse labeling periods was quantified (Fig. 5B) . Based on these data, 18 Ϯ 5% of the PAM-1 protein is phosphorylated on Ser 937 immediately following its biosynthesis into the ER in AtT-20 cells.
To determine whether the amount of PAM-1 protein phosphorylated at Ser 937 changed as the protein matured, AtT-20 PAM-1 cells were labeled for 15 min with [ 35 S]Met and either extracted immediately or chased for 2 or 4 h and then extracted. Aliquots of cell extracts were immunoprecipitated with the PHM or the Ser(P) 937 antiserum. As expected, 117-kDa PAM-1 protein was detected with both antisera immediately following the 15-min labeling period (Fig. 5C ). Over the 2-h chase, the subset of PAM-1 proteins phosphorylated at Ser 937 exhibited the same 3-4-kDa increase in apparent molecular mass as did the total population of PAM-1 proteins (22, (45) (46) (47) . Following the 4-h chase, there was a 2-fold increase in the amount of labeled PAM-1 protein that was phosphorylated at Ser 937 compared with the value immediately after the 15-min pulse. Again, due to the low number of methionine residues in membrane PAL, we were unable to accurately quantify the 70-kDa PAL phosphorylated at Ser 937 . Overall, these data suggest that PAM-1 proteins that have matured and passed through the Golgi complex into secretory granules are more heavily phosphorylated at Ser 937 than newly synthesized PAM-1 proteins still in the ER. When newly synthesized PAM-1 was trapped in the ER by lowering the temperature to 15°C, no significant change in its level of phosphorylation at Ser 937 occurred (data not shown). It is not clear whether the low temperature used for this experiment could have affected kinase activity, thus contributing to this response. (35), we exposed AtT-20 cells to phorbol 12-myristate 13-acetate (PMA) and used the Ser(P) 937 antibody to determine whether PAM phosphorylation increased and in which compartments phosphorylation of PAM at Ser 937 occurred (Fig.  6A) . The staining intensity increased 5 min following the addition of PMA to the medium and increased further at the 15-min time point. Following the 15-min PMA stimulation, an increase in the amount of PAM-1 phosphorylated at Ser 937 is apparent both in vesicles located near the cell surface (arrows) and in the perinuclear TGN region. An altered distribution of PAM in response to PMA treatment cannot be discerned using antisera to the CD (Fig. 6A) or to PHM (data not shown), indicating that only a fraction of the total PAM protein is phosphorylated in response to drug treatment (as shown in Fig.  5 ). The localized change in staining intensity following PMA treatment indicates that only the PAM protein in a specific subcellular compartment undergoes phosphorylation.
PAM-1 Phosphorylation at Ser 937 Occurs in Response to
To quantify the increased phosphorylation of Ser 937 in response to PMA treatment, AtT-20 PAM-1 cells were stimulated for 0, 5, or 15 min with PMA, extracted, and subjected to Western blot analyses (Fig. 6B) . As expected, the pattern of PAM proteins visualized by the PAL antibody was not altered in response to PMA stimulation. In contrast, a robust stimulation was observed with the Ser(P) 937 antiserum, with more PAM protein phosphorylated after 5 and 15 min of PMA treatment. Despite the approximately equal amounts of 120-kDa PAM-1 and 70-kDa PAL detected by the PAL antibody, the 70-kDa membrane PAL was more heavily phosphorylated than the 120-kDa PAM protein following PMA stimulation.
AtT-20 PAM-1/S937D Cells Have a Distinct Phenotype for Internalized PAM-1-To further define the role of phosphorylation in the routing of membrane PAM-1 in the endocytic pathway, live cells were incubated with an antibody directed against a luminal epitope of PAM. Previously, this technique was used to establish that antibody internalized by PAM-1/ S937A cells is misrouted to lysosomes (35) . In the current study, the behavior of antibody internalized by PAM-1/S937D cells was examined.
AtT-20 PAM-1 and PAM-1/S937D cells were incubated with PAL antibody for 10 min and chased in antibody-free medium before immunostaining to track the internalized PAM-antibody complex. Following the 10-min chase, the immunostaining profiles for the PAM-1 and PAM-1/S937D cells were indistinguishable (Fig. 7, A and D) . For both cell types, large vesicular staining was observed throughout the cells, including the processes and tips of the cells, with some concentration of antibody in the perinuclear region. A similar immunostaining pattern was observed for antibody internalized by PAM-1/S937A cells following a 10-min chase (35) . Thus, the AtT-20 PAM-1/S937D cells did not demonstrate a distinct pattern during the early stages of internalization. Following a 30-min chase, internalized antibody was again localized in a punctate vesicular pattern in the PAM-1/S937D cells (Fig. 7E) ; while many vesicles were collected in the perinuclear region, some vesicles remained in the processes of the cells. Following the same chase period, for the PAM-1 cells, internalized antibody was localized to a more compact perinuclear region (Fig. 7B) that stained with the TGN38 antibody (data not shown). Few large vesicular structures were detected, although some vesicles also remained in the processes of the PAM-1 cells. Following the 60-min chase (Fig. 7F) , the internalized antibody remained spread throughout the PAM-1/ S937D cells in a diffuse punctate vesicular pattern. Furthermore, the staining pattern for the PAM-1/S937D cells after the 60-min chase was similar to the pattern observed following the 30-min chase. In contrast, antibody internalized by PAM-1 cells, following the 60-min chase, had collected in the perinuclear area (Fig. 7C) , in a compact region corresponding to the TGN. Overall, these data suggest that phosphorylation of PAM-1 at Ser 937 plays a role at a later stage of PAM-1 internalization.
To further distinguish the role of phosphorylation in the early and late stages of internalization, a paradigm involving temperature blocks was used to trap internalized proteins in early or late endosomal compartments (41) . By definition, the early stage of internalization involves movement of protein from the cell surface into early endosomes; routing from late endosomes to the TGN or to lysosomes, which are more dis- persed in AtT-20 cells, occurs at a late stage of internalization. Initially, AtT-20 PAM-1 and PAM-1/S937D cells were incubated with PAL antibody at 4°C for 60 min to permit labeling of PAM protein on the cell surface and to prevent internalization (41) . The cells were fixed and observed by immunofluorescence. Following this labeling period, both cell types showed similar immunostaining profiles with intense staining on the surface of the cells and no intracellular staining (data not shown). The cells were then warmed to 20°C and chased for 10 min in antibody-free medium to allow movement into early endosomes. The AtT-20 PAM-1 and PAM-1/S937D cells demonstrated similar staining patterns with large vesicular structures present in the processes and tips of the cells and in the perinuclear region (Fig. 8, A and D) .
To sequester internalized proteins in late endosomal compartments, AtT-20 PAM-1 and PAM-1/S937D cells were incubated with PAL antibody for 90 min at 20°C (41) . The immunostaining profiles for the two cell types were again similar, with distinct vesicular structures observed in the processes, tips, and perinuclear region of the cells (data not shown). The cells were then warmed to 37°C for 10 or 60 min to assess the routing of internalized proteins past late endosomal compartments. Following the 10-min chase at 37°C (Fig. 8, B and E) , the immunostaining profiles for both cell types were still indistinguishable with distinct vesicular structures collected in the perinuclear region and vesicles scattered throughout the processes and tips of the cells. However, following the 60-min chase at 37°C, the PAM-1 and PAM-1/S937D cells had distinct internalization profiles. For the AtT-20 PAM-1 cells (Fig. 8C) , immunostaining was primarily observed in the perinuclear region, whereas for the AtT-20 PAM-1/S937D cells (Fig. 8F) , a diffuse punctate vesicular staining pattern was observed. Thus, PAM phosphorylation at Ser 937 affects internalization at a point late in the endocytic pathway.
Antibodies Internalized by PAM-1/S937D Do Not Co-localize with a Lysosomal Marker or a Mannose 6-Phosphate Receptor
Antibody-To determine if antibody internalized by PAM-1/ S937D was routed to lysosomes, cells incubated with PAL antibody for 10 min at 37°C and chased in antibody-free medium for 30 min at 37°C were visualized with a lysosomal marker antibody (LAMP-1) (Fig. 9A) . The internalized PAMantibody complex (red) was localized to the TGN region in the PAM-1 cells and remained in distinct vesicular structures localized to the perinuclear region, cellular processes, and tips of the processes in the PAM-1/S937D cells. In both cell types, lysosomes (green) were detected throughout the perinuclear region, processes, and tips of the cells. At this stage of internalization, very little co-localization of antibody internalized by PAM-1 or PAM-1/S937D and the lysosomal marker occurred. This remained true for cells chased for 60 min at 37°C as well (data not shown).
The CI-MPR antibody was selected as a marker for endosomal compartments. CI-MPR-ligand complexes are transported directly from the TGN into clathrin-coated vesicles that fuse with late endosomes. CI-MPR-ligand complexes are also indirectly transported into late endosomes via internalization from the cell surface (34) . AtT-20 PAM-1, PAM-1/S937A, and PAM-1/S937D cells were incubated with PAL antibody for 10 min at 37°C and chased for 30 min at 37°C in antibody-free medium before fixation and incubation with the CI-MPR antibody (Fig.  9B) . Internalized PAM-antibody complexes (red) were again observed as distinct vesicular structures localized to the TGN region in the PAM-1 and PAM-1/S937A cells and were distributed throughout the perinuclear region and processes of the PAM-1/S937D cells. For all three cell types, CI-MPR (green) was detected in distinct vesicular structures located throughout the cells. Antibody internalized by PAM-1 or PAM-1/S937A cells was not co-localized with the endosomal compartments containing CI-MPR during this stage of internalization. Although antibody internalized by PAM-1/S937D cells was localized to vesicular structures, it did not overlap with the recycling endosomal compartment containing the CI-MPR. DISCUSSION The routing of integral membrane PAM to secretory granules involves information contained in both luminal domains, as demonstrated by the efficient targeting of soluble PHM and PAL to regulated secretory granules (20, 48) . Crucial routing information is also contained in the 86-amino acid cytosolic CD of PAM (23, 29) . A simple working model representing PAM-1 routing through the secretory pathway in AtT-20 cells is presented in Fig. 10 . Following synthesis and N-glycosylation in the ER, integral membrane PAM-1 travels through the Golgi/ TGN, where maturation of oligosaccharides occurs (step 1). Upon entry into immature secretory granules (step 2), integral membrane PAM-1 is cleaved to produce soluble PHM and membrane PAL. Soluble PHM is released by constitutive-like secretion (steps 3 and 9) or stored in secretory granules (20) . Large amounts of PAM-1 and 70-kDa membrane PAL exit secretory granules via the constitutive-like pathway and recycle to the TGN (steps 3 and 8). Only a small fraction of integral membrane PAM resides on the cell surface and is internalized into endosomes before recycling to the TGN (steps 5, 6, and 8) .
Role of phosphorylation of PAM at Ser 937 in the Biosynthetic Trafficking of PAM-1-Western blot analysis, immunostaining, and immunoprecipitation using the Ser (P) 937 -specific antibody demonstrated that PAM-1 was phosphorylated on Ser 937 . At least one other site on the PAM-1 CD was phosphorylated, because PAM-1/S937D was still labeled by inorganic 32 P. Immunostaining of PAM-1 cells with the Ser(P) 937 antibody determined that a significant fraction of the PAM-1 phosphorylated at Ser 937 was localized to the perinuclear region of the cell and at the tips of processes. In response to brief stimulation with phorbol ester, phosphorylation of PAM-1 on Ser 937 increased, with newly phosphorylated protein appearing both in the perinuclear, TGN region and at the margins of the cell. Furthermore, following PMA stimulation, 70-kDa membrane PAL was more heavily phosphorylated than 120-kDa PAM-1.
Phosphorylation of PAM-1 on Ser 937 first occurred at the time of its biosynthesis (Fig. 10) . The faint diffuse staining observed throughout the AtT-20 PAM-1 cells with the Ser(P) 937 antibody may represent the small amount of PAM-1 in the ER at steady-state (Fig. 2D) . Furin also undergoes phosphorylation in the ER (37), while CI-MPR does not (49) . We estimate that one-fifth of the PAM-1 protein was phosphorylated at Ser 937 immediately following biosynthesis. Mature PAM-1 proteins were more heavily phosphorylated at Ser 937 , so phosphorylation of PAM-1 on Ser 937 must also occur at additional locations in the cell. Despite the fact that Ser 937 is subject to phosphorylation in the ER, oligosaccharide maturation (Fig. 10, step 1 ) and entry into immature secretory granules (Fig. 10, step 2) were indistinguishable for PAM-1, PAM-1/S937A, and PAM-1/ S937D. In addition, the biosynthesis and initial cleavage of PAM-1 did not depend on the phosphorylation state of Ser 937 . The synthesis and processing of cation-dependent mannose 6-phosphate receptor in Madin-Darby canine kidney cells were also unaffected by phosphorylation state (34) .
While all of the newly synthesized PAM-1 and PAM-1/S937D was recovered following the 4-h chase, half of the PAM-1/S937A underwent intracellular degradation, and the amount secreted via the constitutive-like pathway (Fig. 10, steps 3 and 9) was reduced 3-fold. The simplest explanation for these observations is that recycling of PAM-1 into immature secretory granules requires phosphorylation of Ser 937 . Four different observations support this hypothesis. First, phorbol ester stimulation of Ser 937 phosphorylation is localized to a perinuclear compart- ment. Second, the PAM-1 phosphorylated in response to a cytosolic Ca 2ϩ -stimulated, staurosporine-blockable protein kinase is localized to a microsomal fraction (35) . Third, PAM-1 truncated immediately following the transmembrane domain is unable to recycle to secretory granules and is also cleaved only half as well as wild-type PAM-1 (23) . Finally, antibody internalized by PAM-1/S937A cells is routed to lysosomes after internalization from the cell surface (35) . Overall, these data support the hypothesis that phosphorylation of Ser 937 plays an important role in preventing PAM entry into lysosomes (Fig.  10, step 7 ) both during recycling from immature secretory granules to the TGN and after internalization from the cell surface.
Role (29) . In AtT-20 cells expressing PAM-1 with Tyr 936 mutated to Ala 936 , the majority of the bound antibody remained at or near the cell surface (29) . Although many proteins utilize Tyr-based internalization signals in their cytosolic COOH-terminal domains, none has been shown to undergo phosphorylation at a Ser within the internalization motif. A Y 762 KGL motif is a determinant for targeting furin to endosomes from the cell surface and also acts as a signal to retrieve furin from the cell surface and recycle it to the TGN (25) . A Y 2363 SKV sequence acts as the internalization signal for the CI-MPR (50), whereas cation-dependent mannose 6-phosphate receptor has both a Y 45 RGV internalization motif and a unique internalization signal, F 13 PHLAF (27) . The polymeric immunoglobulin receptor has two tyrosine-based internalization motifs with the second, Y 734 SAF, playing the most important role (51, 52) . Varicella-zoster virus glycoprotein I (Y 582 AGL) (33) and TGN38 (SDY 333 QRL) (53) both have tyrosine-based internalization motifs.
Since antibody was internalized at similar rates and into similar early endocytic compartments in PAM-1/S937A cells in which PAM-1 could not be phosphorylated at Ser 937 and in PAM-1/S937D cells in which a permanently phosphorylated state of PAM-1 at Ser 937 was mimicked, the phosphorylation state of Ser 937 was not important for PAM-1 internalization from the cell surface (Fig. 10, step 5) . Even when chased for periods up to 90 min at 20°C to allow access to late endosomes (Fig. 10, step 6 ), no differences between cell types were detected. Despite the fact that Tyr 936 plays a crucial role in PAM-1 internalization (29), phosphorylation of the adjacent Ser 937 is without effect on early endocytosis. As for PAM-1, the phosphorylation of CI-MPR (49) and furin (37) does not affect early endocytosis. In contrast, phosphorylation of cell surface polymeric immunoglobulin receptor at Ser 726 , which is distant from the two Tyr-based internalization motifs (Tyr  668 and  Tyr  734 ) , slows the rate of receptor internalization, prolonging its life at the cell surface until ligand is bound (51) .
Phosphorylation at Ser 937 plays a role late in internalization. Following a 60-min chase, antibody internalized by PAM-1 cells was collected in the TGN, while antibody internalized by the PAM-1/S937D cells exhibited a diffuse punctate vesicular pattern (Fig. 8) . Antibody internalized by PAM-1/S937A cells was routed to lysosomes (35) (Fig. 10, step 7) . In contrast, antibody internalized by PAM-1/S937D cells was not co-localized with the lysosomal marker, LAMP-1. Based on these data, we concluded that phosphorylation of PAM-1 at Ser 937 was crucial for preventing the movement of PAM-1 protein from late endocytic compartments into lysosomes (Fig. 10, step 7) . Newly synthesized PAM-1 and PAM-1 internalized from the cell surface may enter the same late endocytic compartment. Thus, the failure to phosphorylate Ser 937 would lead to intracellular degradation of newly synthesized PAM-1 and to the appearance of internalized PAM antibody in lysosomes. The fact that PAM-1 protein that is phosphorylated at Ser 937 following exposure to PMA resides in what could be a late endosomal compartment is consistent with this suggestion.
Although antibody internalized by PAM-1/S937D cells was unable to recycle to the TGN, the biosynthetic trafficking of PAM-1/S937D was indistinguishable from that of PAM-1. This observation suggests that PAM-1 may go through an essential dephosphorylation step at Ser 937 before it can be recycled from the endocytic pathway to the TGN (Fig. 10, step 8) . PAL antibody internalized by the PAM-1, PAM-1/S937A, and PAM-1/ S937D cells was also not co-localized with the CI-MPR marker following a 30-min chase. Since CI-MPR marks TGN to both late endosomal compartments and recycling endocytic compartments (54), we concluded that PAM-1 does not reside primarily in these compartments at this stage of internalization. However, it remains possible that PAM-1 and CI-MPR pass through common endosomal compartments. 
